Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule

Adenoviral vectors are being developed as vaccines against infectious agents and tumour-associated antigens, because of their ability to induce cellular immunity. However, the protection afforded in animal models has not easily translated into primates and clinical trials, underlying the need for im...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Rollier, CS, Spencer, AJ, Sogaard, KC, Honeycutt, J, Furze, J, Bregu, M, Gilbert, SC, Wyllie, D, Hill, AVS
Natura:	Journal article
Lingua:	English
Pubblicazione:	Springer Nature 2020

Documenti analoghi

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
di: Alcock, R, et al.
Pubblicazione: (2010)

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
di: Spencer, A, et al.
Pubblicazione: (2012)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
di: Spencer, A, et al.
Pubblicazione: (2014)

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
di: Alexandra J Spencer, et al.
Pubblicazione: (2012-01-01)

Simian adenoviruses as vaccine vectors
di: Morris, S, et al.
Pubblicazione: (2016)

Simian adenoviruses as vaccine vectors
di: Morris, S, et al.
Pubblicazione: (2016)

Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines.
di: Larsen, K, et al.
Pubblicazione: (2009)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
di: Warimwe, G, et al.
Pubblicazione: (2013)

Uncovering the mechanisms of adenovirus vector immunogenicity
di: Dicks, M, et al.
Pubblicazione: (2013)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
di: Dicks, M, et al.
Pubblicazione: (2011)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
di: Reyes-Sandoval, A, et al.
Pubblicazione: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
di: Reyes-Sandoval, A, et al.
Pubblicazione: (2012)

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses
di: Rollier, C, et al.
Pubblicazione: (2016)

New vectored vaccines for malaria.
di: Hill, A, et al.
Pubblicazione: (2008)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
di: Provine, N, et al.
Pubblicazione: (2021)

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines
di: Dold, C, et al.
Pubblicazione: (2023)

Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions
di: Denice Weklak, et al.
Pubblicazione: (2021-07-01)

Modification of antigen impacts on memory quality after adenovirus vaccination.
di: Colston, J, et al.
Pubblicazione: (2016)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
di: Dicks, M, et al.
Pubblicazione: (2012)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
di: Matthew D J Dicks, et al.
Pubblicazione: (2012-01-01)

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
di: Dudareva, M, et al.
Pubblicazione: (2009)

Novel adenovirus vaccine vectors
di: Dicks, M
Pubblicazione: (2013)

Cytokine Responses to Adenovirus and Adenovirus Vectors
di: Svetlana Atasheva, et al.
Pubblicazione: (2022-04-01)

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
di: Dold, C, et al.
Pubblicazione: (2023)

Novel Adenovirus Vector-Based Vaccines for HIV
di: Letvin N, et al.
Pubblicazione: (2005-12-01)

Rapid-response manufacturing of adenovirus-vectored vaccines
di: Joe, CCD, et al.
Pubblicazione: (2023)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
di: Cottingham, MG, et al.
Pubblicazione: (2012)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
di: Cottingham, MG, et al.
Pubblicazione: (2011)

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
di: L. Coughlan, et al.
Pubblicazione: (2018-03-01)

Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults
di: Coughlan, L, et al.
Pubblicazione: (2018)

Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner
di: Provine, NM, et al.
Pubblicazione: (2022)

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
di: Roy Chad J, et al.
Pubblicazione: (2011-11-01)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
di: Sheerin, D, et al.
Pubblicazione: (2021)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
di: Folegatti, P, et al.
Pubblicazione: (2021)

Viral vectors as vaccine platforms: from immunogenicity to impact
di: Ewer (nee Russell), K, et al.
Pubblicazione: (2016)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
di: Cal Koger-Pease, et al.
Pubblicazione: (2023-02-01)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
di: Dicks, M, et al.
Pubblicazione: (2015)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
di: Green, C, et al.
Pubblicazione: (2023)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
di: Dicks, M, et al.
Pubblicazione: (2015)

Identification of 34 novel proinflammatory proteins in a genome-wide macrophage functional screen.
di: Wyllie, D, et al.
Pubblicazione: (2012)